Vyome Holdings, Inc.
Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Princeton, New Jersey.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q2 | -0.10 | $26,955 | -$7M |
| 2026 Q1 | -0.17 | $31,591 | -$1M |
| 2025 Q4 | -0.21 | $36,551 | -$1M |
| 2025 Q3 | -29.42 | $34,627 | $4M |
| 2025 Q2 | -9.00 | $1M | -$4M |
| 2025 Q1 | 9.42 | $1M | -$2M |
| 2024 Q4 |
| -60.31 |
| $2M |
| -$687,000 |
| 2024 Q3 | -77.67 | $2M | -$311,000 |